Table 1 Sensitivity of MCA (*≥11 or **≥15 U/mL cut-off values), CEA, TPA, CA15.3 in the early detection of 19 relapses during an intensive post-operative follow-up with tumour markers.
| Â | CE or PI of tumour markers as the initial pathological finding of relapse | ||||
|---|---|---|---|---|---|
Tumour marker type | aRelapses (total, n) | Sensitivity (%) | Tumour marker increase | Lead time (months) m + sd (range) | |
| Â | Â | Â | type | n | Â |
*MCA | 13 | 68 | CE PI | 8 5 | 7.1 ± 6.8 (0–22) |
CEA | 2 | 10 | CE PI | 0 2 | 2.0 ± 2.8 (0–4) |
TPA | 5 | 26 | CE PI | 3 2 | 3.2 ± 4.4 (0–9) |
CA15.3 | 6 | 32 | CE PI | 5 1 | 4.7 ± 5.8 (0–14) |
**MCA | 10 | 53 | CE PI | 7 3 | 6.5 ± 6.8 (0–18) |
CEA | 3 | 16 | PI | 3 | 7.3 ± 9.4 (0–18) |
TPA | 8 | 42 | CE PI | 6 2 | 2.9 ± 4.0 (0–9) |
CA15.3 | 6 | 32 | CE PI | 5 1 | 4.7 ± 5.8 (0–14) |